• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节病:免疫发病机制与免疫标志物

Sarcoidosis: Immunopathogenesis and Immunological Markers.

作者信息

Loke Wei Sheng Joshua, Herbert Cristan, Thomas Paul S

机构信息

Inflammation and Infection Research Centre, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia ; Department of Respiratory Medicine, Prince of Wales Hospital, Randwick, NSW 2031, Australia.

Inflammation and Infection Research Centre, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.

出版信息

Int J Chronic Dis. 2013;2013:928601. doi: 10.1155/2013/928601. Epub 2013 Jul 25.

DOI:10.1155/2013/928601
PMID:26464848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4590933/
Abstract

Sarcoidosis is a multisystem granulomatous disorder invariably affecting the lungs. It is a disease with noteworthy variations in clinical manifestation and disease outcome and has been described as an "immune paradox" with peripheral anergy despite exaggerated inflammation at disease sites. Despite extensive research, sarcoidosis remains a disease with undetermined aetiology. Current evidence supports the notion that the immune response in sarcoidosis is driven by a putative antigen in a genetically susceptible individual. Unfortunately, there currently exists no reliable biomarker to delineate the disease severity and prognosis. As such, the diagnosis of sarcoidosis remains a vexing clinical challenge. In this review, we outline the immunological features of sarcoidosis, discuss the evidence for and against various candidate etiological agents (infective and noninfective), describe the exhaled breath condensate, a novel method of identifying immunological biomarkers, and suggest other possible immunological biomarkers to better characterise the immunopathogenesis of sarcoidosis.

摘要

结节病是一种多系统肉芽肿性疾病,总是累及肺部。它是一种临床表现和疾病转归存在显著差异的疾病,被描述为一种“免疫悖论”,尽管疾病部位存在炎症加剧,但外周存在无反应性。尽管进行了广泛研究,结节病的病因仍未明确。目前的证据支持这样一种观点,即在遗传易感个体中,结节病的免疫反应由一种假定的抗原驱动。不幸的是,目前尚无可靠的生物标志物来界定疾病的严重程度和预后。因此,结节病的诊断仍然是一个棘手的临床挑战。在这篇综述中,我们概述了结节病的免疫学特征,讨论了支持和反对各种候选病因(感染性和非感染性)的证据,描述了呼出气冷凝物这一识别免疫生物标志物的新方法,并提出了其他可能的免疫生物标志物,以更好地描述结节病的免疫发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ccc/4590933/dce88c29daa0/IJCD2013-928601.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ccc/4590933/a834392b2f9e/IJCD2013-928601.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ccc/4590933/dce88c29daa0/IJCD2013-928601.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ccc/4590933/a834392b2f9e/IJCD2013-928601.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ccc/4590933/dce88c29daa0/IJCD2013-928601.002.jpg

相似文献

1
Sarcoidosis: Immunopathogenesis and Immunological Markers.结节病:免疫发病机制与免疫标志物
Int J Chronic Dis. 2013;2013:928601. doi: 10.1155/2013/928601. Epub 2013 Jul 25.
2
The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.结节病的免疫标志物在外呼气和外周血中的潜在作用,作为未来的诊断和监测技术。
Inflammopharmacology. 2011 Apr;19(2):55-68. doi: 10.1007/s10787-011-0079-3. Epub 2011 Feb 13.
3
The immunopathogenesis of sarcoidosis.结节病的免疫发病机制。
J Autoimmun. 2024 Dec;149:103247. doi: 10.1016/j.jaut.2024.103247. Epub 2024 May 10.
4
Interleukin-12 family cytokines and sarcoidosis.白细胞介素-12家族细胞因子与结节病
Front Pharmacol. 2014 Oct 27;5:233. doi: 10.3389/fphar.2014.00233. eCollection 2014.
5
The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review.呼气生物标志物在结节病中的作用:系统评价。
J Breath Res. 2019 Jun 24;13(3):036015. doi: 10.1088/1752-7163/ab1284.
6
Etiology of sarcoidosis: does infection play a role?结节病的病因:感染是否起作用?
Yale J Biol Med. 2012 Mar;85(1):133-41. Epub 2012 Mar 29.
7
Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art.结节病的临床表现、发病机制及治疗:最新进展
J Clin Med. 2020 Jul 24;9(8):2363. doi: 10.3390/jcm9082363.
8
Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics.结节病:临床表现、免疫发病机制和治疗学。
JAMA. 2011 Jan 26;305(4):391-9. doi: 10.1001/jama.2011.10.
9
Measurement of neopterin, TGF-β1 and ACE in the exhaled breath condensate of patients with sarcoidosis.测定结节病患者呼出气冷凝液中的新蝶呤、TGF-β1 和 ACE。
J Breath Res. 2013 Dec;7(4):046003. doi: 10.1088/1752-7155/7/4/046003. Epub 2013 Oct 4.
10
MicroRNAs in pulmonary sarcoidosis: A systematic review.肺结节病中的微小RNA:一项系统综述。
Respir Investig. 2020 Jul;58(4):232-238. doi: 10.1016/j.resinv.2020.02.008. Epub 2020 Apr 15.

引用本文的文献

1
Latent microbial reactivation and immune dysregulation in sarcoidosis: bridging pathogenesis and precision therapeutics.结节病中的潜在微生物再激活与免疫失调:连接发病机制与精准治疗
Front Med (Lausanne). 2025 Aug 15;12:1625915. doi: 10.3389/fmed.2025.1625915. eCollection 2025.
2
The Role of in the Etiopathogenesis of Sarcoidosis: Current Insights and Future Study Directions.[具体物质]在结节病病因发病机制中的作用:当前见解与未来研究方向
Int J Mol Sci. 2025 Jul 11;26(14):6652. doi: 10.3390/ijms26146652.
3
Clinical and Demographic Characteristics of Dermatoses with Bimodal Distribution Pattern: A Concise Review.

本文引用的文献

1
Exhaled breath condensate: a promising source for biomarkers of lung disease.呼出气冷凝物:一种有前景的肺部疾病生物标志物来源。
ScientificWorldJournal. 2012;2012:217518. doi: 10.1100/2012/217518. Epub 2012 Dec 17.
2
Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers.应用判别分析评估炎症生物标志物联合检测对结节病患者肺功能恶化的预测价值。
Inflamm Res. 2013 Mar;62(3):325-32. doi: 10.1007/s00011-012-0585-9. Epub 2012 Dec 23.
3
Sarcoidosis.结节病。
具有双峰分布模式的皮肤病的临床和人口统计学特征:简要综述
Indian Dermatol Online J. 2025 Sep 1;16(5):717-724. doi: 10.4103/idoj.idoj_1288_24. Epub 2025 Jun 12.
4
Pulmonary fibrosis in sarcoidosis.结节病中的肺纤维化。
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Sep 13;40(3):e2023027. doi: 10.36141/svdld.v40i3.14830.
5
Dual pathology: paraneoplastic sarcoidosis emerging at the time of progression from smouldering to symptomatic myeloma.双重病变:冒烟型向症状性骨髓瘤进展时出现的副肿瘤性肉样瘤病。
BMJ Case Rep. 2023 Jul 25;16(7):e252917. doi: 10.1136/bcr-2022-252917.
6
Lymphocyte Subsets and Pulmonary Nodules to Predict the Progression of Sarcoidosis.淋巴细胞亚群与肺结节对结节病进展的预测作用
Biomedicines. 2023 May 13;11(5):1437. doi: 10.3390/biomedicines11051437.
7
Detection of Anti-Vimentin Antibodies in Patients with Sarcoidosis.结节病患者中抗波形蛋白抗体的检测
Diagnostics (Basel). 2022 Aug 11;12(8):1939. doi: 10.3390/diagnostics12081939.
8
Sarcoidosis - A review article.结节病——一篇综述文章。
J Oral Maxillofac Pathol. 2022 Apr-Jun;26(2):242-253. doi: 10.4103/jomfp.jomfp_373_21. Epub 2022 Jun 28.
9
Emerging insights in sarcoidosis: moving forward through reverse translational research.结节病研究新进展:通过反向转化医学研究不断前进。
Am J Physiol Lung Cell Mol Physiol. 2022 Apr 1;322(4):L518-L525. doi: 10.1152/ajplung.00266.2021. Epub 2022 Feb 23.
10
A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccine.两种疾病的故事:结节病、COVID-19 以及双重 RAS 抑制和破伤风类毒素疫苗的新治疗选择。
Med Hypotheses. 2021 Jul;152:110619. doi: 10.1016/j.mehy.2021.110619. Epub 2021 Jun 1.
Immunol Allergy Clin North Am. 2012 Nov;32(4):487-511. doi: 10.1016/j.iac.2012.08.005.
4
Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expression.结节病 Th17 细胞是 ESAT-6 抗原特异性的,但表现出 IFN-γ 表达减少。
J Clin Immunol. 2013 Feb;33(2):446-55. doi: 10.1007/s10875-012-9817-6. Epub 2012 Oct 18.
5
MicroRNA-29 in the adaptive immune system: setting the threshold.微小 RNA-29 在适应性免疫系统中的作用:设定阈值。
Cell Mol Life Sci. 2012 Nov;69(21):3533-41. doi: 10.1007/s00018-012-1124-0. Epub 2012 Sep 13.
6
Exhaled breath condensate: an overview.呼出气冷凝液:概述。
Immunol Allergy Clin North Am. 2012 Aug;32(3):363-75. doi: 10.1016/j.iac.2012.06.014. Epub 2012 Jul 20.
7
The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.结节病性肺纤维化的临床和免疫学特征。
Transl Res. 2012 Nov;160(5):321-31. doi: 10.1016/j.trsl.2012.03.005. Epub 2012 Apr 10.
8
Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.结节病中分子结构变异对血清 Krebs von den Lungen-6 水平的影响。
J Transl Med. 2012 Jul 11;10:111. doi: 10.1186/1479-5876-10-111.
9
Pathogenesis of sarcoidosis.结节病的发病机制。
Presse Med. 2012 Jun;41(6 Pt 2):e275-87. doi: 10.1016/j.lpm.2012.03.018. Epub 2012 May 15.
10
Utility of exhaled breath condensates across respiratory diseases.呼出气冷凝物在各种呼吸道疾病中的应用
Am J Respir Crit Care Med. 2012 Apr 15;185(8):791-2. doi: 10.1164/rccm.201202-0212ED.